2nd Department of Surgical Oncology, Regional Institute of Oncology (IRO), Iasi, Romania.
Grigore T Popa University of Medicine and Pharmacy Iasi, Iasi, Romania.
Ann Surg Oncol. 2024 Oct;31(10):6514-6525. doi: 10.1245/s10434-024-15571-8. Epub 2024 Jun 10.
Considered to reflect a patients' biological age, frailty is a new syndrome shown to predict surgical outcomes in elderly patients. In view of the increasing age at which patients are proposed oncological liver surgery and the morbidity associated with it, we attempted to perform a systematic review and meta-analysis to compare morbidity and mortality between frail and nonfrail patients after liver resections.
The study was registered with PROSPERO. A systematic search of PubMed and EMBASE databases was performed for all comparative studies examining surgical outcomes after liver resections between frail and nonfrail patients.
Ten studies were included based on the selection criteria with a total of 71,102 patients, split into two groups: frail (n = 17,167) and the control group (n = 53,928). There were more elderly patients with a lower preoperative albumin level in the frail group (p = 0.02, p = 0.001). Frail patients showed higher rates of morbidity with more major complications and a higher incidence of postoperative liver failure (p < 0.001). Mortality (p < 0.001) and readmission rate (p = 0.021) also was higher in frail patients.
Frailty seems to be a solid predictive risk factor of morbidity and mortality after liver surgery and should be considered a selection criterion for liver surgery in at-risk patients.
衰弱被认为反映了患者的生物年龄,是一种新的综合征,已被证明可预测老年患者的手术结果。鉴于提出进行肿瘤肝脏手术的患者年龄越来越大,以及与之相关的发病率,我们试图进行系统评价和荟萃分析,以比较肝脏切除术后虚弱和非虚弱患者的发病率和死亡率。
该研究已在 PROSPERO 上注册。对 PubMed 和 EMBASE 数据库进行了系统检索,以查找所有比较研究,这些研究检查了虚弱和非虚弱患者肝脏切除术后手术结果之间的差异。
根据选择标准,有 10 项研究符合纳入标准,共纳入 71102 例患者,分为两组:虚弱组(n=17167)和对照组(n=53928)。虚弱组的老年患者更多,术前白蛋白水平更低(p=0.02,p=0.001)。虚弱患者的发病率更高,主要并发症更多,术后肝功能衰竭的发生率更高(p<0.001)。死亡率(p<0.001)和再入院率(p=0.021)也更高。
衰弱似乎是肝脏手术后发病率和死亡率的可靠预测危险因素,应将其视为高危患者肝脏手术的选择标准。